The Public Library of Science (PLOS) was founded in 2000 by biomedical scientists Harold E. Varmus, Patrick O. Brown and Michael Eisen for the purpose of granting open access to the public about scientific research papers. An open letter was sent to scientific publishers encouraging them to all distribution of their research literature through an on-line publication like the National Library of Medicine's PubMed Central. In response to a less than receptive response, PLOS launched a nonprofit scientific and medical publishing venture in 2003. PLOS articles are available free on-line and appear immediately on the web site for no charge. PLOS received start-up funds from the Gordon and Betty Moore Foundations and has received various other foundation endowments for their not for profit enterprise.
Cardiology
Brief pulses of ultrasound delivered to nerves near the kidney produced a clinically meaningful drop in blood pressure in people whose hypertension did not respond to a triple cocktail of medications, reports a new study ...
1 hour ago
0
0
Diseases, Conditions, Syndromes
A weighted "lottery" designed to increase access to the antiviral drug remdesivir during the May-July 2020 COVID-19 surge for those most affected by the coronavirus, including members of the Black, Latinx and indigenous communities, ...
1 hour ago
0
0
Patients with idiopathic pulmonary fibrosis (IPF), a rare lung disease that causes shortness of breath and low oxygen levels because of lung scarring, have worse outcomes if they live in poor neighborhoods, according to research ...
1 hour ago
0
0
By removing "race correction" from the interpretation of pulmonary function test (PFT) results, Black individuals were shown to have a significantly higher prevalence and severity of lung disease, according to research presented ...
1 hour ago
0
0
Cardiology
An innovative cardiac rehabilitation intervention started earlier and more custom-tailored to the individual improved physical function, frailty, quality-of-life, and depression in hospitalized heart failure patients, compared ...
1 hour ago
0
0
The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai. The fully ...
1 hour ago
0
0
Heart failure (HF) - when the heart can't pump enough blood and oxygen through the body—affects approximately 6.2 million adults in the United States and is the primary cause of hospitalization in the elderly. Unfortunately, ...
1 hour ago
0
0
Oncology & Cancer
Research led by scientists at Children's Cancer Institute and published this week in the international journal, Clinical Cancer Research, has found a combination of therapies that appears to be highly effective against high-risk ...
1 hour ago
0
0
Cardiology
An unusual study that had thousands of heart disease patients enroll themselves and track their health online as they took low- or regular-strength aspirin concludes that both doses seem equally safe and effective for preventing ...
13 hours ago
1
88
Environment
(HealthDay)—If you live in the path of hurricanes , the U.S. Consumer Product Safety Commission (CPSC) is urging you to be prepared.
12 hours ago
0
18
